>_ QFI Terminal
TerminalStocks › BEAT

HeartBeam, Inc. (BEAT) Stock

Healthcare · Medical - Healthcare Information Services · US
$0.82 -31.68%
Last updated Sep 20, 2026 15:00 UTC

BEAT Key Statistics

Market Cap$28.24M
P/E (TTM)-1.30
P/S (TTM)
P/B (TTM)10.62
Revenue (TTM)$0.00
EPS (TTM)$-0.63
Dividend Yield
ROE (TTM)-571.06%
Net Margin0.00%
Gross Margin0.00%
52W High$1.78
52W Low$0.80
Analyst ViewBuy
Price Target$5.00
Employees21
Volume7,759,444

About HeartBeam, Inc.

HeartBeam, Inc., a medical technology company, primarily focuses on telemedicine solutions for the detection and monitoring of cardiac disease outside a healthcare facility setting. The company also focuses on providing diagnostic data to physicians with care management of patients with cardiovascular disease. Its telehealth product comprises a credit card sized electrocardiogram machine and a cloud-based diagnostic software system to address the rapidly growing field of remote patient monitoring. The company was incorporated in 2015 and is headquartered in Santa Clara, California.

CEO: Robert Eno. Company website

BEAT — Frequently Asked Questions

What is the BEAT stock price today?

HeartBeam, Inc. (BEAT) trades at $0.82, down 31.68% on the day, as of Sep 20, 2026 15:00 UTC.

What is HeartBeam, Inc.'s market cap?

HeartBeam, Inc. has a market capitalisation of $28.24M, calculated from the live BEAT share price and shares outstanding.

What is the P/E ratio of BEAT?

BEAT has no meaningful price-to-earnings ratio: HeartBeam, Inc. lost $0.63 per share over the last twelve months, and a P/E is only defined on positive earnings.

How much revenue does HeartBeam, Inc. make?

HeartBeam, Inc. generated revenue of $0.00 over the trailing twelve months.

What is the 52-week range for BEAT?

BEAT has traded between $0.80 and $1.78 over the past 52 weeks, and the last price is 53.9% below that high.

Is HeartBeam, Inc. profitable?

Yes. HeartBeam, Inc. keeps 0.00% of revenue as net income over the trailing twelve months.

What is the analyst price target for BEAT?

Wall Street analysts rate BEAT Buy, with an average price target of $5.00, 509.9% above the current price.

What sector is HeartBeam, Inc. in?

HeartBeam, Inc. is classified under the Healthcare sector and the Medical - Healthcare Information Services industry, and is domiciled in US .

Who is the CEO of HeartBeam, Inc.?

Robert Eno is the chief executive of HeartBeam, Inc., which employs 21 people.

Where can I track BEAT in real time?

QFI Terminal shows BEAT with live charts, full financials, the options chain with gamma exposure, institutional ownership and analyst ratings on one screen. The free plan has no time limit and asks for no card.

See BEAT live in QFI Terminal

Interactive charts, full financials, options chain, gamma exposure, ownership and analyst ratings, all in one institutional-grade terminal.

Open BEAT in Terminal See plans

Medical - Healthcare Information Services stocks

BTSG BrightSpring Health Services, Inc. Common Stock TDOC Teladoc Health, Inc. EVH Evolent Health, Inc. TEM Tempus AI, Inc. HQY HealthEquity, Inc. OMCL Omnicell, Inc. HNGE Hinge Health, Inc. DOCS Doximity, Inc.

More Healthcare stocks

UNH UnitedHealth Group Incorporated CVS CVS Health Corp. MCK McKesson Corporation COR Cencora, Inc. NVO Novo Nordisk A/S CI Cigna Corporation CAH Cardinal Health, Inc. ELV Elevance Health Inc.